The purpose of the study was to develop an SNEDDS to improve the solubility and bioavailability of pitavastatin. The solubility of pitavastatin in different oils, surfactants, and co-surfactants was determined and a pseudo-ternary phase diagram was constructed. The SNEDDS was characterized by zeta-sizer, zeta-potential, FTIR, DSC, and TGA. Release and permeation of pitavastatin from the SNEDDS was studied for 12 and 24 h, respectively. The lipolysis test, RBC lysis, effect on lipid profile, and pharmacokinetics were studied. The SPC3 formulation showed a 104 ± 1.50 nm particle size, a 0.198 polydispersity index (PDI), and a –29 zeta potential. FTIR, DSC, and TGA showed the chemical compatibility and thermal stability. The release and permeation of pitavastatin from SPC3 was 88.5 ± 2.5% and 96%, respectively. In the lipolysis test, the digestion of SPC3 yielded a high amount of pitavastatin and showed little RBC lysis. The lipid profile suggested that after 35 days of administration of the SNEDDS, there was a marked decrease in TC, LDL, and triglyceride levels. The SNEDDS of SPC3 showed an 86% viability of Caco-2 cells. Pharmacokinetics of SPC3 showed improved values of C_max, T_max, half-life, MRT, AUC, and AUMC compared to the reference formulation. Our study demonstrated that the SNEDDS effectively enhanced the solubility and bioavailability of a BCS class II drug.

In the current study, nitrofurazone- (NFZ) and lidocaine-loaded (LD) silica microspheres were fabricated to address pathological indications of skin infections. The microspheres were prepared by the sol–gel method applying the Box–Behnken design and evaluated for size distribution, morphology, zeta potential, physico-chemical compatibility, XRD, thermogravimetric analysis, antibacterial and cytotoxicity activities. The comparative in vitro drug release study of microspheres revealed a 30% release of NFZ and 33% of LD after 8 h. The microspheres showed 81% percentage yield (PY) and 71.9% entrapment efficiency. XRD patterns confirmed the entrapment of NFZ–LD in silica microspheres with a significant reduction in crystallinity of the drugs. Thermal and FTIR studies proved the absence of any profound interactions of the formulation ingredients. The smooth spherical microspheres had a −28 mV zeta potential and a 10–100 µm size distribution. In vitro antibacterial activities of the NFZ–LD microspheres showed an increased zone of inhibition compared to pure drug suspensions. The in vivo efficacy tested on rabbits showed a comparatively rapid wound healing with complete lack of skin irritation impact. The cytotoxicity studies revealed more acceptability of silica microspheres with negligible harm to cells. The study suggests that the NFZ- and LD-loaded silica microspheres would be an ideal system for accelerating and promoting rapid healing of various acute and chronic wounds.

Background: Wound healing is a typical biological process that the human body accomplishes through well-defined stages. The complexity of the healing process continues to be a significant health challenge. Multifunctional polymeric bilayer wound dressings have emerged as a new treatment option, as they resemble the bilayer structure of skin. Methods: Here, we developed a bilayer film with two distinct features, i.e., a primary sodium alginate (Na-Alg)-based sustained release layer incorporated with bergamot essential oil (BEO) and a secondary immediate release layer of hydroxypropyl methyl cellulose (HPMC) and hydroxyethyl cellulose (HEC) loaded with the antibacterial drug ofloxacin (OFX). Using the double solvent casting technique. Results: The resultant bilayer films exhibited good folding endurance and swelling capability. The antibacterial potential was appraised by assessing their capability to hinder the growth of S. aureus (40 mm zone of inhibition) and E. coli (46 mm zone of inhibition). A DPPH assay confirmed the anti-oxidant ability of the incorporated essential oil. The outcomes of the X-ray diffraction and FTIR analysis support the even and complete dispersion of the oil and drug into the polymeric matrix without any unwanted interaction. The SEM results revealed a slightly microstructured surface view, while microporous structures were discovered in the cross-section due to the presence of the oil and drug. In the in vivo wound model, the developed bilayer films demonstrated a quicker rate of wound closure (98.5% in 12 days) and avoided wound infection. Histological studies verified that the created dressing enhanced the deposition of mature collagen and promoted epithelialization. Conclusions: As a result, the unique blend of anti-inflammatory and antibacterial properties in bilayer films can significantly offer fresh perspectives for developing sophisticated, multipurpose wound dressings to hasten the healing of cutaneous wounds.